Laserfiche WebLink
Docusign Envelope ID: A89F5B7A-EA414585-AE34-A3E2A4104705 <br />authorizes the Plaintiffs' Executive Committee to execute and file on behalf of the <br />Governmental Entity a Stipulation of Dismissal with Prejudice for each of the <br />manufacturers listed in paragraph 1 above substantially in the form found at <br />hilps://nationalopioidsettlement.com/"dditional-settlements/. <br />4. The Governmental Entity agrees to the terms of each of the Secondary Manufacturers' <br />Settlements pertaining to Participating Subdivisions as defined therein. <br />S. By agreeing to the terms of each of the Secondary Manufacturers' Settlements and <br />becoming a Releasor, the Governmental Entity is entitled to the benefits provided therein, <br />including, if applicable, monetary payments beginning after the Effective Date. <br />6. The Governmental Entity agrees to use any monies it receives through each of the <br />Secondary Manufacturers' Settlements solely for the purposes provided therein. <br />7. The Governmental Entity submits to the jurisdiction of the court and agrees to follow the <br />process for resolving any disputes related to each Secondary Manufacturer's Settlement as <br />described in each of the Secondary Manufacturers' Settlements.' <br />8. The Governmental Entity has the right to enforce each of the Secondary Manufacturers' <br />Settlements as provided therein. <br />9. The Governmental Entity, as a Participating Subdivision, hereby becomes a Releasor for all <br />purposes in each of the Secondary Manufacturers' Settlements, including without <br />limitation all provisions related to release of any claims,' and along with all departments, <br />agencies, divisions, boards, commissions, districts, instrumentalities of any kind and <br />attorneys, and any person in his or her official capacity whether elected or appointed to <br />serve any of the foregoing and any agency, person, or other entity claiming by or through <br />any of the foregoing, and any other entity identified in the definition of Releasor, provides <br />for a release to the fullest extent of its authority. As a Releasor, the Governmental Entity <br />hereby absolutely, unconditionally, and irrevocably covenants not to bring, file, or claim, or <br />to cause, assist or permit to be brought, filed, or claimed, or to otherwise seek to establish <br />liability for any Released Claims against any Released Entity in each of the Secondary <br />Manufacturers' Settlements in any forum whatsoever. The releases provided for in each of <br />the Secondary Manufacturers' Settlements are intended by the Parties to be broad and shall <br />be interpreted so as to give the Released Entities in each of the Secondary Manufacturers' <br />Settlements the broadest possible bar against any liability relating in any way to Released <br />' See Settlement Agreement for Alvogen, Inc. Section VII.F.2; Settlement Agreement for Apotex Corp. Section <br />VILF.2; Settlement Agreement for Amneal Pharmaceuticals LLC Section VII.F.2; Settlement Agreement for Hikma <br />Pharmaceuticals USA Inc. Section VII.F.2; Settlement Agreement for Indivior Section VI.F.2; Settlement Agreement <br />for Mylan Section VI.F.2; Settlement Agreement for Sun Pharmaceutical Industries, Inc. Section VILF.2; Settlement <br />Agreement for Zydus Pharmaceuticals (USA) Inc. Section VILF.2. <br />' See Settlement Agreement for Alvogen, Inc. Section XI; Settlement Agreement for Amneal Pharmaceuticals LLC <br />Section X; Settlement Agreement for Apotex Corp. Section XI; Settlement Agreement for Hikma Pharmaceuticals <br />USA Inc. Section XI; Settlement Agreement for Indivior Section X; Settlement Agreement for Mylan Section X; <br />Settlement Agreement for Sun Pharmaceutical Industries, Inc. Section XI; Settlement Agreement for Zydus <br />Pharmaceuticals (USA) Inc. Section XI. <br />1>}1 <br />K-2 I <br />®r— <br />a'r <br />